Location History:
- Robbinsdale, MN (US) (1992 - 1997)
- Champlin, MN (US) (1993 - 2023)
Company Filing History:
17 out of 8,742 
3 out of 61 
1 out of 8 
Years Active: 1992-2023
Title: **Paul V Trescony: Innovator in Cerebrospinal Fluid Management**
Introduction
Paul V Trescony, a notable inventor based in Champlin, Minnesota, is recognized for his significant contributions to medical technology, particularly in cerebrospinal fluid management. With a robust portfolio of 22 patents, Trescony has consistently pursued innovations that aim to improve patient outcomes and enhance therapeutic techniques.
Latest Patents
Among his latest patented inventions is the "Cerebrospinal fluid shunt having long term anti-occlusion agent delivery." This invention encompasses a shunt designed for at least partial implantation into a patient. It features an elongated conduit with at least one lumen allowing fluid flow. The device includes a proximal end for bodily fluids and a distal end for fluid discharge, along with a long-term source of an occlusion-resistant agent. A portion of this agent can permeate through the conduit, contributing to its effectiveness. Additionally, the invention incorporates associated kits and systems, further showcasing Trescony’s commitment to advancing medical solutions.
Career Highlights
Trescony has worked with leading medical firms such as Medtronic, Inc. and Medtronic PS Medical, Inc. His experience in these prestigious companies has facilitated the development of innovative medical devices and solutions, prominently impacting the field of healthcare technology.
Collaborations
Throughout his career, Trescony has collaborated with notable professionals in the industry, including Michael F. Wolf and James R. Keogh. These collaborations have fostered a rich environment for innovation and have played a crucial role in the success of his projects and inventions.
Conclusion
Paul V Trescony's dedication to innovation in medical technology, particularly through the development of cerebrospinal fluid management devices, has led to numerous patents and advancements that benefit patients and the healthcare industry as a whole. His contributions continue to influence the way medical professionals approach the management of cerebrospinal fluid, ensuring that patient care evolves with cutting-edge solutions.